Henan Taloph Pharmaceutical Stock Co Ltd Cash Flow Quality Index
Henan Taloph Pharmaceutical Stock Co Ltd cash flow quality index. Henan Taloph Pharmaceutical Stock Co Ltd (600222) has a Cash Flow Quality Index of 3.80x as of September 2025. Operating cash flow of CN¥22.69 Million exceeds net income of CN¥5.98 Million, indicating high earnings quality where cash backs reported profits. See 600222 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Henan Taloph Pharmaceutical Stock Co Ltd (1998–2025)
Cash flow quality index of Henan Taloph Pharmaceutical Stock Co Ltd from 1998 to 2025. Historical Cash Flow Quality Index for Henan Taloph Pharmaceutical Stock Co Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Henan Taloph Pharmaceutical Stock Co Ltd (600222) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Henan Taloph Pharmaceutical Stock Co Ltd Cash Flow Quality Index by Year (1998–2025)
Henan Taloph Pharmaceutical Stock Co Ltd cash flow quality index by year from 1998 to 2025. Year-by-year earnings quality comparison for Henan Taloph Pharmaceutical Stock Co Ltd. For the full cash flow conversion analysis, see 600222 cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.79x | CN¥47.16 Million | CN¥60.00 Million | ▲ +206.2% |
| 2024 | -0.74x | CN¥-39.59 Million | CN¥53.49 Million | ▼ -173.7% |
| 2023 | 1.00x | CN¥43.74 Million | CN¥43.56 Million | ▼ -93.2% |
| 2021 | 14.70x | CN¥99.66 Million | CN¥6.78 Million | ▲ +452.5% |
| 2020 | 2.66x | CN¥73.43 Million | CN¥27.60 Million | ▲ +172.8% |
| 2019 | 0.98x | CN¥41.53 Million | CN¥42.57 Million | ▼ -69.0% |
| 2017 | 3.14x | CN¥23.17 Million | CN¥7.37 Million | ▼ -91.7% |
| 2016 | 38.10x | CN¥70.60 Million | CN¥1.85 Million | ▲ +240.7% |
| 2015 | 11.18x | CN¥49.27 Million | CN¥4.41 Million | ▲ +526.6% |
| 2014 | 1.78x | CN¥89.54 Million | CN¥50.17 Million | ▲ +1488.0% |
| 2013 | -0.13x | CN¥-6.65 Million | CN¥51.70 Million | ▼ -104.7% |
| 2012 | 2.73x | CN¥87.45 Million | CN¥32.04 Million | ▲ +54094.8% |
| 2011 | 0.01x | CN¥105.20K | CN¥20.89 Million | ▲ +100.7% |
| 2010 | -0.72x | CN¥-20.00 Million | CN¥27.82 Million | ▼ -205.8% |
| 2009 | 0.68x | CN¥21.45 Million | CN¥31.56 Million | ▼ -9.7% |
| 2008 | 0.75x | CN¥18.13 Million | CN¥24.09 Million | ▼ -24.8% |
| 2007 | 1.00x | CN¥21.34 Million | CN¥21.31 Million | ▲ +990.3% |
| 2006 | 0.09x | CN¥1.59 Million | CN¥17.36 Million | ▲ +459.3% |
| 2005 | 0.02x | CN¥276.30K | CN¥16.83 Million | ▼ -98.6% |
| 2004 | 1.15x | CN¥18.25 Million | CN¥15.94 Million | ▲ +613.9% |
| 2003 | 0.16x | CN¥3.74 Million | CN¥23.31 Million | ▼ -76.8% |
| 2002 | 0.69x | CN¥7.47 Million | CN¥10.78 Million | ▼ -63.5% |
| 2001 | 1.90x | CN¥55.03 Million | CN¥29.00 Million | ▲ +9194.3% |
| 2000 | 0.02x | CN¥875.36K | CN¥42.87 Million | ▼ -99.2% |
| 1999 | 2.58x | CN¥99.32 Million | CN¥38.44 Million | ▼ -4.6% |
| 1998 | 2.71x | CN¥28.04 Million | CN¥10.35 Million | — |